Up to $3M is available from NHMRC e-ASIA JRP to support Australian participation and collaboration in the international joint research projects in the East Asia region.


NHMRC e-ASIA JRP (Joint Research Program)

The National Health and Medical Research Council (NHMRC) e-ASIA Joint Research Program (JRP) scheme will support Australian participation and collaboration in leading international collaborative research through the e-ASIA Joint Research Program (e-ASIA JRP). The Joint Research Program formulates and supports international joint research projects in the East Asia region.

The e-ASIA JRP selects research projects through an open call for proposals. Fields of cooperation are decided among the e-ASIA participating member organisations and funding is for up to three years.



NHMRC is the Australian Government’s key entity for managing investment in, and integrity of, health and medical research. The NHMRC e-ASIA JRP Grant scheme is a component of the Portfolio Budget Statement Program 1.1: Health and Medical Research, which contributes to Outcome 1: Improved health and medical knowledge. NHMRC works with stakeholders to plan and design the grant program according to the National Health and Medical Research Council Act 1992 (NHMRC Act) and the CGRGs.

NHMRC awards grants through several research funding schemes to advance health and medical knowledge and to improve the health status of all Australians. NHMRC invests in the highest quality research and researchers, as determined through peer review, across the four pillars of health and medical research: biomedical, clinical, public health and health services research.



The  objectives of the NHMRC e-ASIA JRP Grants are:

  • to promote the science and technology community in the East-Asia region, make use of abundant human resources in the region and generate “novel knowledge”, “competitive technology” and “reforms of systems” which are the source of dynamism in the economy and society. Namely, the Program seeks innovation in the region.
  • to pursue synergistic, supplemental and leveraged effects by multilateral cooperation, which is possible not by a single nation but by a combination of best potentials in the region
  • to seek genuine partnerships for mutual contribution and mutual allotments of outcomes.

The intended outcomes of the NHMRC e-ASIA JRP are:

  • improved health policy development arising from a global perspective
  • ability to understand and adapt knowledge that is generated overseas for use within Australia
  • skills formation at an international level
  • access to facilities and infrastructure that may not be available in Australia
  • enhanced probability of, and opportunities for, innovation and commercialisation
  • opportunities to leverage funding, and the potential for enhanced social rates of return on the national investment
  • greater access to international expertise, and enhanced and earlier access to data
  • enhanced capacity to respond speedily and effectively to epidemics and pandemics and work towards finding solutions
  • diverse approaches to research questions
  • access to and the potential for sharing, scarce research material and resources.



The provisional funding allocation for the NHMRC e-ASIA JRP is $3 million. NHMRC’s Research Committee annually reviews and recommends indicative budget amounts to be awarded across individual funding schemes.

The amount of funding for a NHMRC e-ASIA JRP Grants grant will be based on assessment of the requested budget. Applications must clearly justify the requested duration and budget and how they will support the proposed outcomes of the research. Peer Reviewers will consider this information and may reduce the duration and/or budget to ensure the research aims and objectives can be achieved while ensuring value with money. A reduced budget does not reduce the scope of the proposed research activity.

An NHMRC e-ASIA JRP 2019 grant is awarded for a fixed three-year term.


Eligible Projects

NHMRC is supporting Australian researchers for the following research topics in the e-ASIA JRP health research 8th joint call:

  • Infectious Diseases
  • Antimicrobial and multi-drug resistance
  • Cancer

Further information on the e-ASIA JRP 8th Health Call is available from the e-ASIA website: http://www.the-easia.org/jrp/

Funding provided by NHMRC for a Research Activity must be spent on costs directly incurred in relation to that Research Activity. Further guidance on the expenditure of funding for a Research Activity is provided in the Direct Research Cost Guidelines on the NHMRC website.

NHMRC will only fund Australian components of the project. NHMRC will not fund any components of the projects that are funded by the partnering e-ASIA member countries.


Eligible Applicants

Applications will only be accepted from NHMRC approved Administering Institutions. A list of NHMRC approved Administering Institutions and NHMRC’s Administering Institution policy are available on NHMRC’s website.


Applications must satisfy all the requirements set out in the NHMRC e-ASIA Joint Research Program Grants 2019 Guidelines.

Applications will be excluded from consideration if the following eligibility requirements are not met:

  • There must be a minimum of three member organisations participating in a call topic.
  • Applications specific to each participating member organisation must be completed by the Chief Investigator A (CIA) in their country (e.g. Australian CIA submit to NHMRC while the Japanese CIA submit to Japan Agency for Medical Research and Development).



Applications close 14 May 2019.


More Information

What is the #1 grant for start-ups?

12,000+ companies access the R&D tax incentive per year that yields a CASH REBATE of up to 43.5%.
This might be perfect your start up.
Do you want to know more?

Scroll to Top
R&D Top 10 Consultant Tips

Top 10 Consultant Tips to Maximise the R&D Tax Incentive